Table 1.
Baseline characteristics of patients overall and stratified by catheter loss (n = 155)
| Overall | Patients with Y-TEC peritoneoscopic catheter placement (n = 62) | Patients with open catheter placement (n = 93) | P-value | |
|---|---|---|---|---|
| Age (years), mean (SD) | 55.1 (17.1) | 56.5 (17.9) | 54.2 (16.6) | 0.42 |
| Male, n (%) | 79 (51) | 36 (59) | 42 (45.2) | 0.09 |
| Race, n (%) | 0.39 | |||
| White | 98 (63.2) | 36 (59) | 58 (62.4) | 0.68 |
| African American/other | 57 (36.8) | 24 (41) | 35 (37.6) | |
| Body mass index, median (IQR) | 26 (23–30) | 25 (22–28) | 27.5 (24–32) | 0.02 |
| Cause of ESRD, n (%) | 0.10 | |||
| Diabetes | 50 (32.3) | 13 (21.3) | 37 (39.8) | |
| Hypertension | 35 (22.6) | 18 (29.5) | 16 (17.2) | |
| Glomerulonephritis/HIVAN | 37 (23.9) | 17 (27.9) | 20 (21.5) | |
| Other | 33 (21.3) | 14 (21.5) | 20 (21.5) | |
| PD as first modality | 103 (66.5) | 42 (67.7) | 60 (64.5) | 0.58 |
| Time to first use, n (%) | 0.10 | |||
| ≥2 months | 130 (83.9) | 48 (77.4) | 82 (88.1) | |
| <2 months | 19 (12.3) | 10 (16.1) | 9 (9.7) | |
| Unknown/never used | 6 (3.8) | 4 (6.5) | 2 (2.2) | |
| Prior abdominal surgery, n (%) | 3 | 0 (0) | 3 (3.2) | 0.17 |
Other causes of ESRD included interstitial nephritis (n = 2), amyloidosis (n = 2), medication induced (n = 6), polycystic kidney disease (n = 5), congenital (n = 3), sickle-cell disease (n = 1), chronic rejection post-transplant (n = 1), acute kidney injury (n = 2) and unknown (n = 11).
IQR, interquartile range; HIVAN, HIV-associated nephropathy.